CHEMOMAB THERAPEUTICS LTD. - AMERICAN DEPOSITARY

1,4200

12-марта-25 16:45:00

15 мин. задержка

Акции

+0,0600

+4,41%

Сегодняшний диапазон

1,3500 - 1,4600

ISIN

N/A

Источник

NASDAQ

Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

09 май 2024 07:00:01 Источник Nasdaq GlobeNewswire
Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

08 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference

02 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update

24 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis

18 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024

02 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis

25 мар 2024 07:06:46 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.